[Form 4] IQVIA Holdings Inc. Insider Trading Activity

Rhea-AI Filing Summary

Braze, Inc. (BRZE) – Form 4 filing

Chief Business Officer Astha Malik reported the sale of 9,001 Class A shares on 28 Jul 2025 under a Rule 10b5-1 trading plan adopted 14 Apr 2025. The shares were sold at a weighted-average price of $30.01 (range $30.00-$30.06), generating roughly $270k in gross proceeds.

Following the transaction, Malik’s beneficial ownership stands at 249,979 shares, of which 222,391 are RSUs. Ownership remains direct. No derivative transactions were reported.

The filing is routine and does not disclose any material corporate events, financial metrics, or changes to executive roles. Investors may view insider selling as a modest negative signal, although the small size (<1% of total ownership) and use of a pre-arranged plan mitigate adverse interpretation.

Positive

• Sale executed under a pre-arranged Rule 10b5-1 plan, limiting concerns about opportunistic trading and insider timing.

Negative

• Insider sale by a senior executive can be perceived as a bearish sentiment indicator, even if small relative to total ownership.

Insights

Financial Analyst

TL;DR: Small, pre-planned C-suite sale; negligible fundamental impact.

The 9,001-share disposition represents <1% of Malik’s holdings and <0.02% of BRZE’s diluted share count. Use of a 10b5-1 plan reduces signaling risk, and remaining ownership (≈$7.5 m at $30) shows continued alignment. No derivatives exercised and no other insiders involved. I classify the filing as non-impactful for valuation or guidance, though technically it skews sentiment slightly negative because it adds to selling pressure and headline risk.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Cherofsky Keriann

(Last) (First) (Middle)

C/O IQVIA HOLDINGS INC.

2400 ELLIS ROAD

(Street)

DURHAM NC 27703

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
IQVIA HOLDINGS INC. [ IQV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See Remarks

3. Date of Earliest Transaction (Month/Day/Year)
07/28/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/28/2025		F		35	D	$197.76	2,875	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

SVP, Corporate Controller

	/s/ Matthew Gilmartin, Attorney-in-Fact for Keriann Cherofsky	07/30/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Braze (BRZE) shares did Astha Malik sell?

The Chief Business Officer sold 9,001 Class A shares.

At what price were the BRZE shares sold?

Shares were sold at a weighted-average price of $30.01, within a $30.00-$30.06 range.

Does the executive still hold Braze shares after the sale?

Yes. Malik retains 249,979 shares, including 222,391 RSUs.

Was the BRZE insider sale part of a 10b5-1 plan?

Yes. The transaction was executed under a Rule 10b5-1 trading plan adopted on 14 Apr 2025.

Are there any derivative securities involved in this filing?

No derivative securities were acquired or disposed of in this Form 4.